Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $500
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Jonathan Block maintains a Hold rating on IDEXX Laboratories and lowers the price target from $510 to $500.
October 10, 2024 | 3:18 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stifel analyst Jonathan Block maintains a Hold rating on IDEXX Laboratories and lowers the price target from $510 to $500.
The Hold rating suggests a neutral stance, indicating that the stock is expected to perform in line with the market. The slight reduction in the price target from $510 to $500 may reflect a modestly less optimistic outlook, but it is not a significant change. Therefore, the short-term impact on the stock price is likely neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100